These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases]. Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180 [TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report. Lissia M; Figus A; Rubino C Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036 [TBL] [Abstract][Full Text] [Related]
6. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Koh MJ; Tay YK Curr Opin Pediatr; 2009 Aug; 21(4):505-10. PubMed ID: 19474732 [TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. French LE; Trent JT; Kerdel FA Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917 [TBL] [Abstract][Full Text] [Related]
8. Toxic epidermal necrolysis: current evidence, practical management and future directions. Chave TA; Mortimer NJ; Sladden MJ; Hall AP; Hutchinson PE Br J Dermatol; 2005 Aug; 153(2):241-53. PubMed ID: 16086734 [TBL] [Abstract][Full Text] [Related]
17. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome. Fromowitz JS; Ramos-Caro FA; Flowers FP; Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723 [TBL] [Abstract][Full Text] [Related]
18. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis. Paquet P; Jacob E; Damas P; Pirson J; Piérard G Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases. Koštál M; Bláha M; Lánská M; Koštálová M; Bláha V; Štepánová E; Malý J J Clin Apher; 2012; 27(4):215-20. PubMed ID: 22407895 [TBL] [Abstract][Full Text] [Related]
20. Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin. Gaitanis G; Spyridonos P; Patmanidis K; Koulouras V; Nakos G; Tzaphlidou M; Bassukas ID Dermatology; 2012; 224(2):134-9. PubMed ID: 22572593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]